The Fort Worth Press - Avant Technologies and Ainnova Explore Integrating Early Detection of Dementia into AI-Powered Preventative Screening Platform

USD -
AED 3.672498
AFN 66.01795
ALL 81.918073
AMD 380.082198
ANG 1.790403
AOA 917.000317
ARS 1451.749668
AUD 1.499855
AWG 1.8025
AZN 1.700141
BAM 1.660779
BBD 2.006725
BDT 121.751979
BGN 1.660725
BHD 0.377041
BIF 2943.593924
BMD 1
BND 1.285546
BOB 6.899392
BRL 5.593024
BSD 0.996315
BTN 89.32611
BWP 13.141537
BYN 2.897914
BYR 19600
BZD 2.003838
CAD 1.37381
CDF 2259.999662
CHF 0.78991
CLF 0.023193
CLP 909.850267
CNY 7.04095
CNH 7.02196
COP 3793.03
CRC 496.671309
CUC 1
CUP 26.5
CVE 93.63218
CZK 20.65465
DJF 177.422642
DKK 6.3437
DOP 62.353521
DZD 129.566957
EGP 47.489902
ERN 15
ETB 154.42113
EUR 0.84919
FJD 2.27745
FKP 0.750114
GBP 0.74135
GEL 2.685028
GGP 0.750114
GHS 11.383785
GIP 0.750114
GMD 73.487596
GNF 8709.274779
GTQ 7.634761
GYD 208.4508
HKD 7.77715
HNL 26.262695
HRK 6.398405
HTG 130.448073
HUF 329.955015
IDR 16785
ILS 3.20254
IMP 0.750114
INR 89.761967
IQD 1305.237594
IRR 42099.999951
ISK 125.680418
JEP 0.750114
JMD 159.029924
JOD 0.708996
JPY 156.04701
KES 128.429994
KGS 87.450116
KHR 3996.739435
KMF 419.00048
KPW 899.999969
KRW 1483.870657
KWD 0.30727
KYD 0.830305
KZT 513.773309
LAK 21581.29819
LBP 89223.786556
LKR 308.472878
LRD 176.352705
LSL 16.642013
LTL 2.95274
LVL 0.60489
LYD 5.406576
MAD 9.120954
MDL 16.868483
MGA 4488.638294
MKD 52.269794
MMK 2100.312258
MNT 3551.223311
MOP 7.984274
MRU 39.714174
MUR 45.980253
MVR 15.459953
MWK 1727.692673
MXN 17.969497
MYR 4.067021
MZN 63.898534
NAD 16.642013
NGN 1455.949607
NIO 36.664685
NOK 10.09705
NPR 142.921436
NZD 1.72015
OMR 0.384497
PAB 0.9964
PEN 3.35527
PGK 4.238734
PHP 58.754044
PKR 279.104565
PLN 3.58065
PYG 6732.108284
QAR 3.64186
RON 4.320201
RSD 99.734007
RUB 78.799672
RWF 1451.2075
SAR 3.75044
SBD 8.146749
SCR 14.142203
SDG 601.5159
SEK 9.219503
SGD 1.287215
SHP 0.750259
SLE 24.049856
SLL 20969.503664
SOS 568.424986
SRD 38.4065
STD 20697.981008
STN 20.802996
SVC 8.718284
SYP 11058.38145
SZL 16.637512
THB 31.190097
TJS 9.166469
TMT 3.5
TND 2.914388
TOP 2.40776
TRY 42.827702
TTD 6.773717
TWD 31.510303
TZS 2470.474018
UAH 41.938114
UGX 3590.23131
UYU 39.052682
UZS 11952.718997
VES 282.15965
VND 26329.5
VUV 120.603378
WST 2.787816
XAF 557.009782
XAG 0.01444
XAU 0.000224
XCD 2.70255
XCG 1.79571
XDR 0.692741
XOF 557.009782
XPF 101.270337
YER 238.502559
ZAR 16.716565
ZMK 9001.206597
ZMW 22.517917
ZWL 321.999592
  • SCS

    0.0200

    16.14

    +0.12%

  • RBGPF

    0.0000

    80.22

    0%

  • CMSC

    -0.0500

    23.12

    -0.22%

  • RYCEF

    -0.3200

    15.36

    -2.08%

  • CMSD

    -0.0500

    23.2

    -0.22%

  • BCC

    -0.5400

    74.23

    -0.73%

  • RELX

    0.2500

    40.98

    +0.61%

  • JRI

    -0.0100

    13.37

    -0.07%

  • RIO

    1.7800

    80.1

    +2.22%

  • NGG

    0.3000

    76.41

    +0.39%

  • BCE

    -0.1100

    22.73

    -0.48%

  • VOD

    0.0400

    12.88

    +0.31%

  • GSK

    -0.0200

    48.59

    -0.04%

  • BTI

    0.3200

    56.77

    +0.56%

  • BP

    0.2000

    34.14

    +0.59%

  • AZN

    0.1900

    91.55

    +0.21%

Avant Technologies and Ainnova Explore Integrating Early Detection of Dementia into  AI-Powered Preventative Screening Platform
Avant Technologies and Ainnova Explore Integrating Early Detection of Dementia into AI-Powered Preventative Screening Platform

Avant Technologies and Ainnova Explore Integrating Early Detection of Dementia into AI-Powered Preventative Screening Platform

LAS VEGAS, NEVADA / ACCESS Newswire / May 27, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced the companies are exploring options to integrate the early detection of dementia into Ainnova's proprietary, AI-powered platform technology, Vision AI. The addition would reinforce the Company's mission of expanding AI-powered early detection and preventative health solutions across the globe.

Text size:

Currently, the Company has identified a promising patented early disease detection technology specializing in the early detection of dementia and is exploring its options to either license the technology globally or potentially acquire the technology altogether. The patented technology combines AI algorithms and hardware based on a 5-minute blood test. Adding the early detection of dementia would expand the offerings in the Company's technology portfolio and enhance the broader vision of the partnership between Avant and Ainnova.

The success of the Company's preventative screening platform involves the deployment of an automated, low-cost retinal imaging device integrated with the Vision AI platform to deliver comprehensive preventive risk screening. Presently, from just two retinal images, blood pressure and some lab test information, the Company's system uses 4 integrated algorithms to assess risks for: (i) cardiovascular disease (CVD), (ii) type 2 diabetes, (iii) liver fibrosis, and (iv) chronic kidney disease (CKD).

Vinicio Vargas, Chief Executive Officer at Ainnova and member of the Board of Directors of the joint venture company, Ai-nova Acquisition Corp., said of the potential expansion of its technology portfolio, "This accessible, fast, and scalable solution is designed to support early intervention and targeted treatment strategies, with the ambition of reaching millions of patients globally in the coming years. Adding the early detection of dementia that this patented technology presents us, would go a long way to making us a leader in the industry of early disease detection."

About Ainnova Tech, Inc.

Ainnova is a Nevada-based healthtech startup with headquarters in San Jose, Costa Rica, and Houston, Texas. Founded by an experienced and innovative team that is dedicated to leveraging artificial intelligence for early disease detection. Recognized with multiple global awards and renowned partnerships with hospitals and medical device companies, we proudly introduce Vision AI - our cutting-edge platform designed to prevent blindness and detect the early onset of diabetes. Explore how Ainnova is revolutionizing healthcare through advanced technology and proactive solutions.

About Avant Technologies Inc.

Avant Technologies Inc. is an emerging technology company developing solutions in artificial intelligence in healthcare. With a focus on pushing the boundaries of what is possible in AI and machine learning, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology.

More information about Avant can be found at https://avanttechnologies.com

You can also follow us on social media at:

https://twitter.com/AvantTechAI
https://www.linkedin.com/company/avant-technologies-ai
https://www.facebook.com/AvantTechAI
https://www.youtube.com/@AvantTechAI

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date after the date of the press release.

Contact:

Avant Technologies Inc.
[email protected]

SOURCE: Avant Technologies Inc.



View the original press release on ACCESS Newswire

H.Carroll--TFWP